MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma. - Labrador, María; Cozzubbo, Sara; Porro, Mariangela; Cumerlato, Michela; Bandini, Cecilia; Mereu, Elisabetta; Paradzik, Tina; Donati, Benedetta; Manicardi, Veronica; Ronchetti, Domenica; D'Agostino, Mattia; Larocca, Alessandra; et al. (Cells (2073-4409), 2026)